September 5, 2025Frontiers in Public HealthOpen Access

Substandard medicines in Nepal: a crisis of access, equity, and a call for action

View Full Paper

Ask AI

Bookmark

Substandard medicines undermine universal health coverage and patient safety, particularly for marginalized communities.
An alarming 15.16% of tested medicine batches failed pharmacopeial standards in Nepal, primarily in public health facilities.
Strengthening regulatory capacity through international frameworks is essential to tackle the substandard medicine crisis.
Addressing this issue is not just about public health but also a matter of health equity and social justice.

Discussion

No takes yet. Share an insight, caveat, or question.

The analysis uncovers the dire impact of substandard medicines on patient safety in Nepal, suggesting urgent regulatory solutions.

Animesh Ghimire (2025) studied this question.

View Full Paper

Ask AI

Bookmark